Global Kidney Transplant Market
Healthcare Services

Kidney Transplant Market Forecast Signals New Revenue Opportunities Through 2030

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Kidney Transplant Market Expansion From $6.74 Billion In 2026 To $8.3 Billion In 2030

The market for kidney transplants has experienced robust expansion. Projections indicate a rise from $6.42 billion in 2025 to $6.74 billion by 2026, reflecting a compound annual growth rate of 5.0%. Factors fueling this expansion during the preceding period include the increasing prevalence of end-stage renal disease, the inherent limitations of dialysis over extended durations, the demonstrable success of transplant procedures, enhancements in transplant facility capabilities, and a greater understanding of the advantages offered by transplantation.

The kidney transplant sector is poised for significant expansion in the coming years, with projections indicating a market valuation reaching $8.31 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.4%. This anticipated expansion over the forecast period stems from a confluence of factors including escalating demand for organ transplantation, pioneering advancements in immunosuppressive drug treatments, a greater acceptance of organs from expanded criteria donors, augmented investments in transplant-related research, and subsequent enhancements in post-transplant survival rates. Key developments anticipated during this timeframe involve a discernible shift favoring kidney transplantation as a preferred treatment over sustained dialysis, a broader implementation of living-donor and paired kidney exchange initiatives, heightened attention on meticulous post-transplant patient surveillance and care, an increase in kidney transplant procedures for pediatric patients, and the attainment of superior outcomes through sophisticated immunosuppressive regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10707&type=smp

Kidney Transplant Market Growth Factors: Which Forces Are Supporting Market Expansion?

The increasing prevalence of kidney-related ailments and the occurrence of kidney failure are anticipated to stimulate advancements within the kidney transplant sector. Kidney disorders and failure signify conditions where the kidneys cease to operate effectively, thereby losing their capacity to regulate bodily chemical balances and eliminate waste products and excess fluid from the bloodstream. Consequently, kidney failure often creates a demand for transplants to reinstate renal functionality and tackle the root causes of these conditions. Illustrating this trend, the American Kidney Fund, a US charitable entity, reported in 2023 that approximately 37 million individuals in the United States were affected by kidney disease, underscoring how the escalation of kidney problems and failure is a key factor fueling the expansion of the kidney transplant market.

Kidney Transplant Market Segments: Where Are The Largest Growth Opportunities?

The kidney transplant market covered in this report is segmented –

1) By Transplant Type: Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor

2) By Age Group: Adult, Pediatrics

3) By End-User: Transplant Centers, Hospitals

Subsegments:

1) By Deceased-Donor Kidney Transplant: Standard Criteria Donor, Extended Criteria Donor

2) By Living-Donor Kidney Transplant: Related Living Donor, Unrelated Living Donor, Paired Kidney Exchange

3) By Expanded Criteria Donor: Older Donors, Donors With Hypertension

Kidney Transplant Market Industry Trends: What Changes Are Reshaping Demand?

Leading players within the kidney transplant sector are actively pursuing innovative advancements, specifically portable hypothermic perfusion systems, with the primary goals of extending the lifespan of donor kidneys, ensuring superior organ preservation throughout transit, and minimizing the number of organs that go unused. Portable hypothermic perfusion systems function as specialized medical equipment that circulates a chilled, oxygen-rich preservation fluid consistently through a donated kidney. This active circulation sustains the organ’s metabolic activity and tissue health, offering a distinct advantage over conventional static cold storage methods where organs are simply kept on ice without any active fluid movement. Illustrating this trend, Paragonix Technologies, a firm based in the United States that manufactures medical devices, obtained clearance from the U.S. Food and Drug Administration (FDA) in January 2025 for its KidneyVault Portable Renal Perfusion System. This particular device marks a substantial leap forward in kidney preservation technology, providing a completely mobile solution for continuous hypothermic perfusion from the initial organ retrieval all the way to the transplantation procedure. It facilitates ongoing, immediate oversight of crucial perfusion indicators like flow rate, pressure levels, and temperature, empowering medical professionals to preserve peak organ quality from the moment of procurement until implantation. This pioneering development contributes to more reliable preservation outcomes, mitigates potential complications linked to older static cold storage techniques, and underscores the increasing drive towards creating cutting-edge technologies designed to broaden the availability of transplantable organs and enhance patient results.

Kidney Transplant Market Major Participants And Competitive Dynamics

Major companies operating in the kidney transplant market are Pfizer Inc, Novartis AG, Astellas Pharma Inc, Veloxis Pharmaceuticals A/S, Bristol-Myers Squibb Company, Sanofi S.A., AbbVie Inc, Roche Holding AG, Merck & Co. Inc, Otsuka Pharmaceutical Co. Ltd, Hansa Biopharma AB, CareDx Inc, TransMedics Group Inc, Immucor Inc, Glycorex Transplantation AB, Alexion Pharmaceuticals Inc, CSL Behring Ltd, Grifols S.A., Kedrion Biopharma S.p.A., BioLife Solutions Inc

Access The Complete Kidney Transplant Market Report:

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Kidney Transplant Market Global Footprint: Which Region Holds Market Leadership?

North Americawas the largest region in the kidney transplant market in 2025.Europeis expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model